In approximately one-third of CML cases, reciprocal ABL1::BCR fusion mRNA was undetectable [59], suggesting that the reciprocal ABL1::BCR fusion gene may not be indispensable, at least for development of CML. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.